IDEXX LABORATORIES INC /DE Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Idexx Laboratories Inc /De quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2016 to Q4 2023.
  • Idexx Laboratories Inc /De Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2023 was $9.01M, a 0.57% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $9.01M +$51K +0.57% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $8.96M +$386K +4.5% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $8.57M +$3.14M +57.9% Dec 31, 2021 10-K 2023-02-16
Q4 2020 $5.43M +$1.38M +34.2% Dec 31, 2020 10-K 2022-02-16
Q4 2019 $4.05M +$837K +26.1% Dec 31, 2019 10-K 2021-02-12
Q4 2018 $3.21M -$142K -4.24% Dec 31, 2018 10-K 2020-02-14
Q4 2017 $3.35M -$832K -19.9% Dec 31, 2017 10-K 2019-02-15
Q4 2016 $4.18M Dec 31, 2016 10-K 2018-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.